Variables | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age |  |  < 0.001 |  |  < 0.001 |
 <60 | Ref |  | Ref |  |
  ≥ 60 | 3.508(1.904–6.464) |  | 3.146(1.699–5.826) |  |
Year of diagnosis | Â | 0.008 | Â | 0.054 |
 1992–2002 | Ref |  |  |  |
 2003–2012 | 0.524(0.333–0.826) |  |  |  |
 2013–2018 | 0.473(0.251–0.89) |  |  |  |
Sex | Â | 0.758 | Â | Â |
 Male |  |  |  |  |
 Female |  |  |  |  |
Race | Â | 0.189 | Â | Â |
 White |  |  |  |  |
 Others |  |  |  |  |
Laterality | Â | 0.051 | Â | 0.115 |
 Unilateral |  |  |  |  |
 Bilateral |  |  |  |  |
 Unknown |  |  |  |  |
Primary site | Â | 0.004 | Â | 0.15 |
 Retina | Ref |  |  |  |
 Choroid | 0.156(0.047–0.52) |  |  |  |
 Ciliary body | 0.286(0.124–0.662) |  |  |  |
 Vitreous | 0.288(0.137–0.606) |  |  |  |
Pathological type |  |  < 0.001 |  | 0.008 |
 DLBCL | Ref |  | Ref |  |
 MALT | 0.144(0.065–0.322) |  | 0.233(0.101–0.534) |  |
 NHL, NOS | 0.587(0.325–1.062) |  | 0.823(0.439–1.543) |  |
 Other/unclassifiedb | 0.59(0.361–0.964) |  | 0.813(0.489–1.353) |  |
Ann arbor stage | Â | 0.057 | Â | Â |
 I to II |  |  |  |  |
 III to IV |  |  |  |  |
 Unknown |  |  |  |  |
Surgery | Â | 0.441 | Â | Â |
 Performed |  |  |  |  |
 No/unknown |  |  |  |  |
Radiotherapy | Â | 0.362 | Â | Â |
 Performed |  |  |  |  |
 No/unknown |  |  |  |  |
Chemotherapy |  |  < 0.001 |  | 0.003 |
 Performed | Ref |  | Ref |  |
 No/unknown | 0.415(0.273–0.632) |  | 0.498(0.316–0.785) |  |